BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2015
View Archived Issues
Anti-annexin II shows potential as a new biomarker for APS
Read More
Resverlogix closes license agreement, enters stock purchase agreement with Hepalink
Read More
Monopar partners with Cancer Research UK and Cancer Research Technology on HuATN-658
Read More
Allergan patents EP2 receptor agonists
Read More
Daiichi Sankyo describes LCAT activators
Read More
Sanofi reports dual GIPR/GLP-1R agonists
Read More
Sunovion Pharmaceuticals reports P2X4 negative modulators
Read More
Bristol-Myers Squibb presents HCV NS5B inhibitors
Read More
Epizyme and Celgene extend research collaboration
Read More
AstraZeneca divests global rights to Entocort
Read More
CB-5083 receives FDA orphan drug designation for multiple myeloma
Read More
FDA orphan drug designation granted to Rett's syndrome candidate sarizotan
Read More
Etodolac and propranolol combination receives U.S. orphan status for malignant glioma
Read More
Genentech's atezolizumab reduces tumor size in phase II urothelial bladder cancer study
Read More
sFLT-1 may enable early diagnosis of sickle cell nephropathy
Read More
FDA approves Rexulti for schizophrenia and major depressive disorder
Read More
Homocitrulline can differentiate acute and chronic renal failure
Read More
Canadian trial investigates novel tumor-targeted oncolytic virus vaccine
Read More
BioDiem and Griffith University receive grant to study targets of BDM-I
Read More
Galectin-3 may be a biomarker of cirrhosis severity
Read More
Imbruvica approved in E.U. for Waldenstrom's macroglobulinemia
Read More
The Scripps Research Institute to study environmental triggers for autoimmune disease
Read More
Novel hyaluronic acid eyedrops promote corneal tissue healing
Read More
Benitec acquires full rights to Hepbarna hepatitis B program
Read More
Novo Nordisk releases results from first phase IIIa study of semaglutide for type 2 diabetes
Read More
EyeGate licenses EGP-437 and delivery technology to Valeant
Read More